(VIANEWS) - AdaptHealth Corp. (AHCO), Immersion Corporation (IMMR), Guess? (GES) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AdaptHealth Corp. (AHCO)
37% sales growth and 3.63% return on equity
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States.
AdaptHealth Corp. 's sales growth this year is anticipated to be 130.9% and 16.8% for next year.
Year-on-year quarterly revenue growth grew by 129.7%, now sitting on 2.1B for the twelve trailing months.
Volume
Today's last reported volume for AdaptHealth Corp. is 662657 which is 30.84% below its average volume of 958230.
AdaptHealth Corp. 's sales growth for the next quarter is 37%. The company's growth estimates for the current quarter and the next is 172.3% and 725%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.63%.
Volatility
AdaptHealth Corp. 's last day, last week, and last month's current intraday variation average was 1.59%, 2.14%, and 2.67%, respectively.
AdaptHealth Corp. 's highest amplitude of average volatility was 4.92% (day), 4.94% (last week), and 5.74% (last month), respectively.
AdaptHealth Corp. 's Stock Yearly Top and Bottom Value
AdaptHealth Corp. 's stock is valued at $17.60 at 00:22 EST, way under its 52-week high of $38.94 and above its 52-week low of $16.55.
AdaptHealth Corp. 's Moving Average
AdaptHealth Corp. 's value is way below its 50-day moving average of $20.62 and way under its 200-day moving average of $23.81.2. Immersion Corporation (IMMR)
19.4% sales growth and 12.16% return on equity
Immersion Corporation, together with its subsidiaries, creates, designs, develops, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia.
Immersion Corporation's sales growth this year is expected to be 15.2% and 9.7% for next year.
Year-on-year quarterly revenue growth declined by 10.9%, now sitting on 35.09M for the twelve trailing months.
Volume
Today's last reported volume for Immersion Corporation is 594841 which is 23.29% below its average volume of 775461.
Immersion Corporation's sales growth for the next quarter is 19.4%. The company's growth estimates for the current quarter and the next is a negative 48.3% and 50%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.16%.
Volatility
Immersion Corporation's last day, last week, and last month's current intraday variation average was 4.52%, 2.96%, and 2.66%, respectively.
Immersion Corporation's highest amplitude of average volatility was 7.01% (day), 6.87% (last week), and 4.55% (last month), respectively.
Immersion Corporation's Stock Yearly Top and Bottom Value
Immersion Corporation's stock is valued at $5.32 at 00:22 EST, way below its 52-week high of $11.68 and way above its 52-week low of $4.46.
Immersion Corporation's Moving Average
Immersion Corporation's value is above its 50-day moving average of $5.28 and way under its 200-day moving average of $6.90.Previous days news about Immersion Corporation(IMMR)
- According to VentureBeat on Friday, 25 February, "He then founded the early VR company Immersion Corporation (1993) and the early AR company Outland Research (2004). "
3. Guess? (GES)
18.1% sales growth and 31.65% return on equity
Guess?, Inc. designs, markets, distributes, and licenses lifestyle collections of apparel and accessories for men, women, and children.
Guess?'s sales growth this year is anticipated to be 38.5% and 6% for next year.
Year-on-year quarterly revenue growth grew by 13%, now sitting on 2.44B for the twelve trailing months.
Volume
Today's last reported volume for Guess? is 566817 which is 41.93% below its average volume of 976201.
Guess?'s sales growth for the next quarter is 18.1%. The company's growth estimates for the current quarter and the next is a negative 3.4% and negative -4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.65%.
Volatility
Guess?'s last day, last week, and last month's current intraday variation average was 4.57%, 2.63%, and 2.82%, respectively.
Guess?'s highest amplitude of average volatility was 5.13% (day), 3.67% (last week), and 5.48% (last month), respectively.
Guess?'s Stock Yearly Top and Bottom Value
Guess?'s stock is valued at $21.89 at 00:22 EST, way under its 52-week high of $31.12 and way above its 52-week low of $19.56.
Guess?'s Moving Average
Guess?'s worth is below its 50-day moving average of $22.65 and under its 200-day moving average of $23.50.4. ABIOMED (ABMD)
15.6% sales growth and 9.88% return on equity
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.
ABIOMED's sales growth this year is expected to be 21.4% and 13.8% for next year.
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 1B for the twelve trailing months.
Volume
Today's last reported volume for ABIOMED is 214853 which is 46.13% below its average volume of 398895.
ABIOMED's sales growth for the next quarter is 15.6%. The company's growth estimates for the present quarter and the next is a negative 12.1% and negative -3.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.88%.
Volatility
ABIOMED's last day, last week, and last month's current intraday variation average was 1.75%, 2.58%, and 3.60%, respectively.
ABIOMED's highest amplitude of average volatility was 3.20% (day), 4.69% (last week), and 5.29% (last month), respectively.
ABIOMED's Stock Yearly Top and Bottom Value
ABIOMED's stock is valued at $312.30 at 00:22 EST, way under its 52-week high of $379.30 and way higher than its 52-week low of $261.27.
ABIOMED's Moving Average
ABIOMED's worth is under its 50-day moving average of $315.13 and under its 200-day moving average of $324.68.5. Interface (TILE)
14.3% sales growth and 17% return on equity
Interface, Inc., a modular flooring company, designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific.
Interface's sales growth this year is anticipated to be 7.5% and 8.7% for next year.
Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 1.14B for the twelve trailing months.
Volume
Today's last reported volume for Interface is 94720 which is 61.69% below its average volume of 247293.
Interface's sales growth for the next quarter is 14.3%. The company's growth estimates for the current quarter and the next is 14.8% and 23.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17%.
Volatility
Interface's last day, last week, and last month's current intraday variation average was 0.98%, 2.04%, and 2.15%, respectively.
Interface's highest amplitude of average volatility was 3.51% (day), 3.27% (last week), and 4.67% (last month), respectively.
Interface's Stock Yearly Top and Bottom Value
Interface's stock is valued at $13.44 at 00:22 EST, way below its 52-week high of $18.03 and way above its 52-week low of $11.02.
Interface's Moving Average
Interface's worth is under its 50-day moving average of $14.70 and under its 200-day moving average of $14.89.6. Option Care Health (OPCH)
12.3% sales growth and 7.87% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
Option Care Health's sales growth this year is anticipated to be 13.1% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 3.32B for the twelve trailing months.
Volume
Today's last reported volume for Option Care Health is 503153 which is 38.12% below its average volume of 813165.
Option Care Health's sales growth for the next quarter is 12.3%. The company's growth estimates for the present quarter and the next is 140% and 850%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.87%.
Volatility
Option Care Health's last day, last week, and last month's current intraday variation average was 1.31%, 2.23%, and 1.93%, respectively.
Option Care Health's highest amplitude of average volatility was 3.07% (day), 3.46% (last week), and 4.36% (last month), respectively.
Option Care Health's Stock Yearly Top and Bottom Value
Option Care Health's stock is valued at $23.65 at 00:22 EST, way below its 52-week high of $28.86 and way above its 52-week low of $16.02.
Option Care Health's Moving Average
Option Care Health's value is below its 50-day moving average of $25.09 and higher than its 200-day moving average of $23.60.7. DENTSPLY SIRONA (XRAY)
11.9% sales growth and 8.46% return on equity
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.
DENTSPLY SIRONA's sales growth this year is expected to be 28.5% and 4.2% for next year.
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 4.24B for the twelve trailing months.
Volume
Today's last reported volume for DENTSPLY SIRONA is 1059870 which is 38.56% below its average volume of 1725260.
DENTSPLY SIRONA's sales growth for the next quarter is 11.9%. The company's growth estimates for the ongoing quarter and the next is a negative 9.2% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.46%.
Volatility
DENTSPLY SIRONA's last day, last week, and last month's current intraday variation average was 0.80%, 1.16%, and 0.93%, respectively.
DENTSPLY SIRONA's highest amplitude of average volatility was 2.67% (day), 2.43% (last week), and 2.71% (last month), respectively.
DENTSPLY SIRONA's Stock Yearly Top and Bottom Value
DENTSPLY SIRONA's stock is valued at $53.54 at 00:22 EST, way under its 52-week high of $69.54 and way above its 52-week low of $48.13.
DENTSPLY SIRONA's Moving Average
DENTSPLY SIRONA's worth is under its 50-day moving average of $53.92 and below its 200-day moving average of $59.41.Previous days news about DENTSPLY SIRONA(XRAY)
- According to Benzinga on Monday, 28 February, "HP Inc. (NYSE: HPQ), Zoom Video Communications, Inc. (NASDAQ: ZM) and DENTSPLY SIRONA Inc. (NASDAQ: XRAY)."
8. Royalty Pharma (RPRX)
6.2% sales growth and 15.4% return on equity
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
Royalty Pharma's sales growth this year is expected to be 5.6% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.29B for the twelve trailing months.
Volume
Today's last reported volume for Royalty Pharma is 1542650 which is 17.65% below its average volume of 1873420.
Royalty Pharma's sales growth for the next quarter is 6.2%. The company's growth estimates for the present quarter and the next is 41.7% and 171.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.4%.
Volatility
Royalty Pharma's last day, last week, and last month's current intraday variation average was 2.05%, 1.97%, and 1.48%, respectively.
Royalty Pharma's highest amplitude of average volatility was 2.80% (day), 3.46% (last week), and 2.54% (last month), respectively.
Royalty Pharma's Stock Yearly Top and Bottom Value
Royalty Pharma's stock is valued at $39.26 at 00:22 EST, way under its 52-week high of $53.23 and way above its 52-week low of $34.86.